Error - something went wrong!
The decision to outsource tasks related to clinical trial transparency and disclosure is dependent on numerous factors. Size of the sponsor organization, level of expertise, and staﬀ availability are just a few of the elements that come into play.
One area often outsourced is Plain-Language Summaries (PLS). At ﬁrst glance, sponsors tend to consider this a relatively simple task, condensing a study’s ﬁndings into a concise presentation, in an easily understood and digestible format.
Download the full whitepaper to learn more.
Other content in this Stream
‘Clicking' with Patients - How Partnerships & Technology Help Meet Patient Needs
Clicking' with Patients: How Partnerships & Technology Can Help Meet Patient Needs Live Webinar Thursday, March 14 at 10 a.m. ET
Top 5 Customer Challenges Solved with TrialScope
Customer Support and TrialScope Community Overview
TrialScope Engage: Before and After Analytics
Managing Disclosure and Maintaining Compliance with Disclosure as a Service
Top 3 Reasons Customers Choose TrialScope
Real Patient Stories: The Trials of Finding Clinical Trials
TrialScope a CARE Finalist for Best Patient-Focused Technology
TrialScope Engage has been named a finalist for Best Patient-Focused Technological Development in the 2019 Clinical & Research Excellence (CARE) awards.
Real Patients Review TrialScope Engage
TrialScope's Structured, Simplified Implementation Process
Helping Patients Find and Engage with Clinical Trials Through a Dedicated Website
"Excellent management, customer service and support."
TrialScope and Vivli Partner to Promote Clinical Trial Transparency
TrialScope, the global leader in clinical trial transparency, compliance and patient engagement solutions, announces a strategic partnership with Vivli, a nonprofit offering a data-sharing platform
With Investors’ Eyes on Biotechs, Biotechs Must Be Transparent
With the government shutdown and public outcry over drug prices, biotech companies face new challenges when courting investors. That means transparency is more important than ever.
Health Literacy the Key to Opening the Door to Clinical Trials
When it comes to health literacy, it’s not enough to just know that clinical trials are out there. As patients, we need information presented in plain language that is easily understood.
"There is nothing better out there!"
A Patients-First Approach to Trial Websites
A Dozen Disclosure & Transparency Predictions for 2019
Clinical trial disclosure and transparency experts Francine Lane and Thomas Wicks make their 2019 predictions on patient-centricity, industry watchdogs, regulatory agencies, medical devices, and data.
How Disclosure as a Service Can Reduce Burden and Raise the Bar for Transparency
8 Reasons to Join TrialScope Community